Combination of clozapine, cariprazine and fluoxetine in treatment-resistant schizophrenia patient with prominent negative symptoms: A Case report

INTRODUCTION: Despite pharmacological advances in the treatment of schizophrenia, significant number of patients are still treatment-resistant. Clozapine is recommended as first-line treatment for treatment-resistant schizophrenia (TRS) in guidelines. Despite the greater efficacy of clozapine over o...

Descripción completa

Detalles Bibliográficos
Autores principales: Everte, I., Pamše-Romāne, A., Taube, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568255/
http://dx.doi.org/10.1192/j.eurpsy.2022.2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568255/
http://dx.doi.org/10.1192/j.eurpsy.2022.2017

Ejemplares similares